期刊論文/Journal Paper

1 陳傑龍(Chen Chieh-Lung)、鄧紀剛(Teng Chikang)、陳韋成(Wei-Cheng Chen)、梁信杰(Shinn-Jye Liang)、涂智彥(Chih-Yen Tu)、施宏謀(Hong-Mo Shih)、鄭婉汝(Cheng, Wan-Ju)、林裕超(Yu-Chao Lin)*、薛博仁(Hsueh, Po-Ren)*,Clinical characteristics and treatment outcomes among the hospitalized elderly patients with COVID-19 during the late pandemic phase in central Taiwan,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2024 Mar,57(2):257-268,SCI
2 陳傑龍(Chen Chieh-Lung)、林裕超(Yu-Chao Lin)、曾皓陽(How-Yang Tseng)、陳韋成(Wei-Cheng Chen)、梁信杰(Shinn-Jye Liang)、涂智彥(Chih-Yen Tu)、薛博仁(Hsueh, Po-Ren)*,High mortality of patients with severe pneumonia caused by respiratory syncytial virus, August 2021eJune 2023, Taiwan,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2024 Feb,57(2024):184-188,SCI
3 (Hao-Che Chang)、(Tung-Hung Su)、(Yu-Tsung Huang)、(Chun-Ming Hong)、(Wang-Huei Sheng)、薛博仁(Hsueh, Po-Ren)、(Jia-Horng Kao)*,Liver dysfunction and clinical outcomes of unvaccinated COVID-19 patients with and without chronic hepatitis B,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2024 Feb,57(1):55-63,SCI
4 余養正(Yong-Cheng Yii)、施宏謀(Hong-Mo Shih)、陳傑龍(Chen Chieh-Lung)、賴紫綸(LAI, ZI-LUN)、許玉龍(Yu-Lung Hsu)、賴佳宏(CHIA HONG-LAI)、薛博仁(Hsueh, Po-Ren)*、周德陽(Der-Yang Cho),Effect of pre-hospitalization use of oral antiviral agents on reducing critical illness and mortality for patients with COVID-19 pneumonia,International Journal of Antimicrobial Agents,2024 Jan,63(1):107020,SCI
5 游家鑫(Jiaxin Yu)、林秀姍(Hsiu-Hsien Lin)、曾坤浩(Kun-Hao Zeng)、林瑜姿(Yu-Tzu Lin)、陳韋成(Wei-Cheng Chen)、田霓(Ni Tien)、卓家楓(Chia-Fong Cho)、梁信杰(Shinn-Jye Liang)、何菁(Lu-Ching Ho)、謝右文(Yow-Wen Hsieh)、許凱程(HSU KAI-CHENG)、何茂旺(Mao-Wang Ho)、薛博仁(Hsueh, Po-Ren)*、周德陽(Der-Yang Cho)*,Prediction of methicillin-resistant Staphylococcus aureus and carbapenem-resistant Klebsiella pneumoniae from flagged blood cultures by combining rapid Sepsityper MALDI-TOF mass spectra with machine learning,International Journal of Antimicrobial Agents,2023 Dec,62(6):,SCI
6 (Yu-Lin Lee)、薛博仁(Hsueh, Po-Ren)*,Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis,CURRENT OPINION IN INFECTIOUS DISEASES,2023 Dec,36(6):481-494,SCI
7 蘇揚迪(Yang-Di Su)、(Chih-Cheng Lai)、林彩秀(Tsai-Hsiu Lin)、陳韋成(Wei-Cheng Chen)、薛博仁(Hsueh, Po-Ren)*,Performance evaluation of the cobas SARS-CoV-2 Duo, a novel qualitative and quantitative assay, for the detection of SARS-CoV-2 RNA,Microbiology Spectrum,2023 Dec,11(6):e0136923,SCI
8 (Tsai-Wen Wan)、(Tai-Fen Lee)、(Xiang-Jun Chen)、(Yun-Tsung Hunag)、(Lee-Jene Teng)、薛博仁(Hsueh, Po-Ren)*、(Hao-Chieh Chiu)*,Performance assessment of the Bruker Biotyper MALDI-TOF MS for the identification of difficult-to-identify viridans group streptococci,JOURNAL OF CLINICAL MICROBIOLOGY,2023 Dec,61(12):e0114323,SCI
9 蕭綾儀(Ling-Yi Xiao)、蘇祐立(Yu-Li Su)*、黃詩喻(Shih-Yu Huang)、陳怡華(Yi-Hua Chen)、薛博仁(Hsueh, Po-Ren)*,Chitinase 3-like-1 Expression in the Microenvironment Is Associated with Neutrophil Infiltration in Bladder Cancer,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2023 Nov,24(21):15990,SCI
10 鄭婉汝(Cheng, Wan-Ju)*、施宏謀(Hong-Mo Shih)、蘇冠賓(Kuan-Pin Su)、薛博仁(Hsueh, Po-Ren),Reply to letter by Dr. Fu and Dr. Chu: Risk factors for poor COVID-19 outcomes in patients with psychiatric disorders,BRAIN BEHAVIOR AND IMMUNITY,2023 Nov,114():255-261,SCI
11 吳承修、李易撰(Li, Yi-Chuan)、彭馨蕾(Shin-Lei Peng)、(Chung-Yu Chen)、陳筱凡(Chen Hsiao-Fan)、薛博仁(Hsueh, Po-Ren)、王韋然(Wang, Wei-Jan)、(Yen-Yi Liu)、(Ciao-Ling Jiang)、張為超(Wei-Chao Chang)、王紹椿(Shao-Chun Wang)、洪明奇(Mien-Chie Hung)*,Coffee as a dietary strategy to prevent SARS-CoV-2 infection,Cell and Bioscience,2023 Nov,13(1):,SCI
12 (Ping-Tao Tseng)、(Bing-Syuan Zeng)、(Chih-Wei Hsu)、(Trevor Thompson)、(Brendon Stubbs)、薛博仁(Hsueh, Po-Ren)、蘇冠賓(Kuan-Pin Su)、(Yen-Wen Chen)、(Tien-Yu Chen)、(i-Cheng Wu)、(Pao-Yen Lin)、(Andre F Carvalho)、(Dian-Jeng Li)、(Ta-Chuan Yeh)、(Cheuk-Kwan Sun)、(Yu-Shian Cheng)、(Yow-Ling Shiue)、(Chih-Sung Liang)、(Yu-Kang Tu)*," The difference in all-cause mortality between COVID-19 patients treated with standard of care plus placebo and those treated with standard of care alone: a network meta-analysis of randomised controlled trials of immunomodulatory kinase inhibitors.",JOURNAL OF THE ROYAL SOCIETY OF MEDICINE,2023 Nov,0(0):1-12,SCI
13 陳智皓(CHEN CHIH-HAO)、劉衍怡(LOW YAN-YI)、劉于瑄(LIU YU-HSUAN)、林秀姍(Hsiu-Hsien Lin)、何茂旺(Mao-Wang Ho)、薛博仁(Hsueh, Po-Ren)*,Rapid detection of gastrointestinal pathogens using a multiplex polymerase chain reaction gastrointestinal panel and its role in antimicrobial stewardship,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2023 Oct,():,SCI
14 高志豪(KAO CHIH-HAO)、劉彥宏(Yen-Hung Liu)、陳維恭(Wei-Kung Chen)、黃芬緯(Fen-Wei Huang)、許太乙(Tai-Yi Hsu)、鄭翰聰(Han-Tsung Cheng)、薛博仁(Hsueh, Po-Ren)、蕭瓊子(Chiung-Tzu Hsiao)、吳詩韻(Wu, SHIH-YUN)、施宏謀(Hong-Mo Shih)*,Value of monocyte distribution width for predicting severe cholecystitis: a retrospective cohort study,CLINICAL CHEMISTRY AND LABORATORY MEDICINE,2023 Sep,61(10):1850-1857,SCI
15 蘇浤傑(SU HUNG-CHIEH)、賴紫綸(LAI ZI-LUN)、張煜昌(Yu-Chang Chang)、鄭孟瑜(Meng-Yu Cheng)、施文心(HSIH WEN HSIN)、陳怡臻(Chen Yi-Jhen)、周家卉(Chia-Hui Chou)、陳傑龍(Chen Chieh-Lung)、林裕超(Yu-Chao Lin)、林彩秀(Tsai-Hsiu Lin)、蕭瓊子(Chiung-Tzu Hsiao)、何茂旺(Mao-Wang Ho)、施宏謀(Hong-Mo Shih)、薛博仁(Hsueh, Po-Ren)*、周德陽(Der-Yang Cho),Genomic characteristics of SARS-CoV-2 variants and their clinical impact on patients with COVID-19 in Taiwan,JOURNAL OF INFECTION,2023 Sep,87():263-265,SCI
16 (Zhi-Ye Yu)、(Chun-Fu Lai)、(Tai-Shuan Lai)、(Shao-Yu Yang)、(Shih-I Chen)、(Mei-Jun Lai)、(Chun-Min Kang)、(Yu-Tsung Huang)、(Yi-Ting Chen)*、薛博仁(Hsueh, Po-Ren)、(Yung-Ming Chen)、(Shuei-Liong Lin),Humeral and cellular immune responses to SARS-CoV-2 vaccination in patients on peritoneal dialysis,JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION,2023 Sep,122(9):922-931,SCI
17 (Jiun-Ling Wang)、(Chih-Cheng Lai)、(Wen-Chien Ko)*、薛博仁(Hsueh, Po-Ren)*,Geographic patterns of in vitro susceptibilities to tigecycline and colistin among worldwide isolates of Acinetobacter baumannii, Escherichia coli and Klebsiella pneumoniae: data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2016 to 2021.,International Journal of Antimicrobial Agents,2023 Sep,62(3):106930,SCI
18 (Zao-Xian Mei)、(Jun-Feng Han)、(Hong-Wei Yu)、(Yuan Zhang)、(Ping Ji)、(Yi Xie)、薛博仁(Hsueh, Po-Ren)*,Detection of serum Aspergillus-specific IgM and IgG antibody levels for the diagnosis of chronic pulmonary aspergillosis developed in patients with tuberculosis,EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES,2023 Sep,42(9):1081-1089,SCI
19 (Chia-Ling Chang)、(Chong-Jen Yu)、薛博仁(Hsueh, Po-Ren)、(Jung-Yien Chien)*,Treatment outcomes and relapse in patients with Mycobacterium avium-intracellulare complex pulmonary disease,Microbiology Spectrum,2023 Sep,11(5):e01640-23,SCI
20 陳怡儒(I-Ru Chen)、汪貴珍(Guei-Jane Wang)*、薛博仁(Hsueh, Po-Ren)、周家卉(Chia-Hui Chou)、鄭隆賓(Long-Bin Jeng)、林惠茹(Hui-Ju Lin)、廖凰君(Huang-Jiun Liao)、賴彬卿(Ping-Chin Lai)、張建國(Jan-Gowth Chang)、黃秋錦(Chiu-Ching Huang),Immune responses and safety of COVID-19 vaccination in atypical hemolytic uremic syndrome patients in Taiwan,Vaccine,2023 Aug,41(2023):5940-5945,SCI
21 陳筱凡(Chen Hsiao-Fan)、王韋然(Wang, Wei-Jan)、陳崇宇(Chen, Chung Yu)、張為超(Wei-Chao Chang)、薛博仁(Hsueh, Po-Ren)、彭馨蕾(Shin-Lei Peng)、吳承修(Wu, Chen-Shiou)、(Yeh Chen)、黃欣瑜(HUANG, HSIN YU)、沈宛柔、王紹椿(Shao-Chun Wang)*、洪明奇(Mien-Chie Hung)*,The natural tannins oligomeric proanthocyanidins and punicalagin are potent inhibitors of infection by SARS-CoV-2,eLife,2023 Aug,12(0):0-0,SCI
22 (Yu-Lin Lee)、(Chun-Eng Liu)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*,In vitro susceptibilities of Stenotrophomonas maltophilia isolates to antimicrobial agents commonly used for related infections: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2004-2020,International Journal of Antimicrobial Agents,2023 Aug,62(2):106878,SCI
23 (Yu-Lin Lee)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*,In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012-2021,International Journal of Antimicrobial Agents,2023 Aug,62(2):106867,SCI
24 (Xiang-Jun Chen)、(Tsai-Wen Wan)、(Qiuo-Ting Chao)、(Lee-Jene Teng)、(Tai-fen Lee)*、(Yu-Tsung Huang)、薛博仁(Hsueh, Po-Ren)*,Applicability of an in-house extraction protocol in a Bruker Biotyper matrix-assisted laser desorption/ionization time-of-flight mass spectrometry system for the identification of Streptococcus agalactiae from broth-enriched vaginal/rectal swab specimens,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2023 Aug,56(4):815-821,SCI
25 薛博仁(Hsueh, Po-Ren)、(Sung-Jung Ho)、(Po-Chuen Hsieh)、(I-Min Liu)、(Shio-Shin Jean)*,Use of Multiple Doses of Intravenous Infusion of Umbilical Cord-Mesenchymal Stem Cells for the Treatment of Adult Patients with Severe COVID-19-Related Acute Respiratory Distress Syndrome: Literature Review,Stem Cells International,2023 Aug,2023():7179592,SCI
26 吳品瀚(WU PIN-HAN)、陳智皓(CHEN CHIH-HAO)、林秀姍(Hsiu-Hsien Lin)、(Kun-Hao Tseng)、(Wen-Chien Ko)、何茂旺(Mao-Wang Ho)、薛博仁(Hsueh, Po-Ren)*,Geographic patterns of antimicrobial susceptibilities for Bacteroides species worldwide: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2007-2020,International Journal of Antimicrobial Agents,2023 Jul,62(1):,SCI
27 王秀慈(Hsiu-Tzu Wang)、白禮源(Li-Yuan Bai)*、王盈中、林慧茹(Hui-Ju Lin)、楊宏仁(Horng-Ren Yang)、薛博仁(Hsueh, Po-Ren)、周德陽(Der-Yang Cho),『Case Series』Circulating tumor cells positivity provides an early detection of recurrence of pancreatic cancer,JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION,2023 Jul,122(7):653-655,SCI
28 (Nai-Chen Cheng)、(Yin Cheng)、(Hao-Chih Tai)、(Kuo-Liong Chien)、(Szu-Hui Wang)、(Yi-Hsuan Chen)、(Chi-Tai Fang)*、薛博仁(Hsueh, Po-Ren)*,High mortality risk of type III monomicrobial gram-negative necrotizing fasciitis: The role of extraintestinal pathogenic Escherichia coli (ExPEC) and Klebsiella pneumoniae,INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES,2023 Jul,132():64-71,SCI
29 (Yu-Lin Lee)、薛博仁(Hsueh, Po-Ren)*,Poor in vitro activity of ceftazidime/avibactam, ceftolozane/tazobactam, and meropenem/vaborbactam against carbapenem-resistant Pseudomonas aeruginosa in India: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2018-2021,JOURNAL OF INFECTION,2023 Jul,87(1):e1-e4,SCI
30 游家鑫(Jiaxin Yu)、林瑜姿(Yu-Tzu Lin)、陳韋成(Wei-Cheng Chen)、曾坤浩(Kun-Hao Zeng)、林秀姍(Hsiu-Hsien Lin)、田霓(Ni Tien)、卓家楓(Chia-Fong Cho)、黃昭瑜(HUANG JHAO-YU)、梁信杰(Shinn-Jye Liang)、何虂菁(Lu-Ching Ho)、謝右文(Yow-Wen Hsieh)、許凱程(HSU KAI-CHENG)、何茂旺(Mao-Wang Ho)、薛博仁(Hsueh, Po-Ren)*、周德陽(Der-Yang Cho)*,Direct prediction of carbapenem-resistant, carbapenemase-producing, and colistin-resistant Klebsiella pneumoniae isolates from routine MALDI-TOF mass spectra using machine learning and outcome evaluation,International Journal of Antimicrobial Agents,2023 Jun,61(6):106799,SCI
31 吳品瀚(WU PIN-HAN)*、陳智皓(CHEN CHIH-HAO)、施文心(HSIH WEN HSIN)、周家卉(Chia-Hui Chou)、齊治宇(Chih-Yu Chi)、何茂旺(Mao-Wang Ho)、(Yu-Tzu Lin)、(Hsiu-Hsien Lin)、(Kun-Hao Tseng)、薛博仁(Hsueh, Po-Ren)*,Emergence of meropenem and levofloxacin resistance in Burkholderia pseudomallei in Taiwan,JOURNAL OF INFECTION,2023 Jun,86(6):E161-E163,SCI
32 (Li-Li Wen)、(Pei-Yun Kuo)、(Tran Thi Dieu Thuy)、(Tran Thi Thuy Duong)、(Yu-Tsung Huang)、薛博仁(Hsueh, Po-Ren)、(Yu-Chen Chen)、(Cheng-Yen Kao)*,Genome-based characterization of conjugative IncHI1B plasmid carrying carbapenemase genes blaVIM-1, blaIMP-23, and truncated blaOXA-256 in Klebsiella pneumoniae NTU107224,INFECTION GENETICS AND EVOLUTION,2023 Jun,110():105420,SCI
33 (Tu-Hsuan Chang)、薛博仁(Hsueh, Po-Ren)、(Yu-Tsung Huang)、(Po-Yu Chen)、(Hung-Jen Tang)、(Jong-Min Chen)*,Prolonged Streptococcus gallolyticus subsp. pasteurianus gut colonization in healthcare workers and potential transmission role in neonatal sepsis,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2023 Jun,56(3):605-611,SCI
34 (Chih-Yen Chang)、(Yu-Lin Lee)、(Yu-Tsung Huang)、(Wen-Chien Ko)、何茂旺(Mao-Wang Ho)、薛博仁(Hsueh, Po-Ren)*,In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Enterobacterales causing urinary tract infection in Taiwan: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2020.,International Journal of Antimicrobial Agents,2023 Jun,61(6):106815,SCI
35 (Chih-Cheng Lai)、(Ping-Ing Lee)、薛博仁(Hsueh, Po-Ren)*,How Taiwan has responded to COVID-19 and how COVID-19 has affected Taiwan, 2020–2022,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2023 Jun,56(3):433-441,SCI
36 (Shio-Shin Jean)、(I-Min Liu)、(Po-Chuen Hsieh)、(Dai-Huang Kuo)、(Yi-Lien Liu)、薛博仁(Hsueh, Po-Ren)*,Off-label use versus formal recommendations of conventional and novel antibiotics for the treatment of infections caused by multidrug-resistant bacteria,International Journal of Antimicrobial Agents,2023 May,61(5):106763,SCI
37 張裕鑫(Yu-Hsin Chang)、蕭瓊子(Chiung-Tzu Hsiao)、張煜昌(Yu-Chang Chang)、賴欣榆(Hsin-Yu Lai)、林秀姍(Hsiu-Hsien Lin)、陳建志(Chien-Chih Chen)、許琳偵(Lin-Chen Hsu)、吳詩韻(Shih-Yun Wu)、施宏謀(Hong-Mo Shih)*、薛博仁(Hsueh, Po-Ren)*、周德陽(Der-Yang Cho)*,Machine learning of cell population data, complete blood count, and differential count parameters for early prediction of bacteremia among adult patients with suspected bacterial infections and blood culture sampling in emergency departments,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2023 May,56():,SCI
38 (Xiaoxin Hao)、(Yichao Shen)、(Nan Chen)、(Weijie Zhang)、(Elizabeth Valverde)、(Ling Wu)、(Hilda L. Chan)、(Zhan Xu)、(Liqun Yu)、(Yang Gao)、(Igor Bado)、(Laura Natalee Michie)、(Charlotte Helena Rivas)、(Luis Becerra Dominguez)、(Sergio Aguirre)、(Bradley C. Pingel)、(Yi-Hsuan Wu)、(Fengshuo Liu)、(Yunfeng Ding)、(David G. Edwards)、(Jun Liu)、(Angela Alexander)、(Naoto T. Ueno)、薛博仁(Hsueh, Po-Ren)、涂智彥(Chih-Yen Tu)、劉良智(Liang-Chih Liu)、(Shu-Hsia Chen)、洪明奇(Mien-Chie Hung)、(Bora Lim)、(Xiang H.-F. Zhang)*,Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal,Cell Stem Cell,2023 May,30(5):648-664,SCI
39 (Ping-Ing Lee)*、薛博仁(Hsueh, Po-Ren),Multisystem inflammatory syndrome in children: A dysregulated autoimmune disorder following COVID-19,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2023 Apr,56(2):236-245,SCI
40 (Prakash Kishore Hazam)、(Chih-Cheng Cheng)、(Wen-Chun Lin)、(Chu-Yi Hsieh)、(Po-Hsien Hsu)、(Yun-Ru Chen)、(Chao-Chin Li)、薛博仁(Hsueh, Po-Ren)、(Jyh-Yih Chen)*,Strategic modification of low-activity natural antimicrobial peptides confers antibacterial potential in vitro and in vivo,EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2023 Mar,249(2023):115131,SCI
41 (Tsung-Ying Yang)、(Sung-Pin Tseng)、(Han-Chen Ho)、(Li-Hsuan Chen)、薛博仁(Hsueh, Po-Ren)、(Po-Liang Lu)、(Chia-Hsuan Lin)、(Liang-Chun Wang 5 6)*,In vitro evaluation of tellurium-based AS101 compound against Neisseria gonorrhoeae infectivity,Microbiology Spectrum,2023 Mar,11(2):e0149622,SCI
42 (Chih-Cheng Lai)、薛博仁(Hsueh, Po-Ren)*,Beyond mental stress-induced myocardial ischemia following the COVID-19 vaccine,BIOMEDICINE-TAIWAN,2023 Mar,1(13):1-2,Other
43 (Tai-Fen Lee)、(Kuan-Yin Lin)、(Sui-Yuan Chang)、(Yu-Tsung Huang)*、薛博仁(Hsueh, Po-Ren)*,Performance of two commercial multiplex polymerase chain reaction assays for the etiological diagnosis of sexually transmitted infections among men who have sex with men,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2023 Feb,56(1):104-110,SCI
44 陳智皓(CHEN CHIH-HAO)、吳品瀚(WU PIN-HAN)、盧敏吉(Min-Chi Lu)、何茂旺(Mao-Wang Ho)、薛博仁(Hsueh, Po-Ren)*,Geographic patterns of carbapenem-resistant, multi-drug-resistant and difficult-to-treat Acinetobacter baumannii in the Asia-Pacific region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020,International Journal of Antimicrobial Agents,2023 Feb,61():,SCI
45 吳品瀚(WU PIN-HAN)、陳智皓(CHEN CHIH-HAO)、(Yu-Tzu Lin)、敖瑀(Yu Ao)、(Kuo-Hsi Lin)、施文心(HSIH WEN HSIN)、周家卉(Chia-Hui Chou)、齊治宇(Chih-Yu Chi)、何茂旺(Mao-Wang Ho)*、薛博仁(Hsueh, Po-Ren)*,Cryptococcus tetragattii Meningitis Associated with Travel, Taiwan,EMERGING INFECTIOUS DISEASES,2023 Feb,29(2):,SCI
46 謝明佑(Ming-You Shie)、方信元(Hsin-Yuan Fang)、甘愷雯(KAN KAI-WEN)、(Chia-Che Ho)、涂智彥(Chih-Yen Tu)、李培志(Lee, Pei-Chih)、薛博仁(Hsueh, Po-Ren)、陳家弘(Chia-Hung Chen)、李凱星(LEE KAI XING ALVIN)、田霓(Ni Tien)、陳建勳(Jian-Xun Chen)、沈祐丞(Shen, Yu-Cheng)、張建國(Jan-Gowth Chang)、(Yu-Fang Shen)、林亭儒(LIN, TING-JU)、(Ben Wang)、洪明奇(Mien-Chie Hung)*、周德陽(Der-Yang Cho)*、陳怡文(Yi-Wen Chen)*,Highly Mimetic Ex Vivo Lung-Cancer Spheroid-Based Physiological Model for Clinical Precision Therapeutics,Advanced Science,2023 Feb,10():2206603,SCI
47 (Chih-Cheng Lai)、(Chi-Kuei Hsu)、(Muh-Yong Yen)、(Ping-Ing Lee)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*,Long COVID: An inevitable sequela of SARS-CoV-2 infection,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2023 Feb,56(1):1-9,SCI
48 (Tsai-Wen Wan)、(Hui-Hui Yeo)、(Tai-Fen Lee)、(Yu-Tsung Huang)、薛博仁(Hsueh, Po-Ren)、(Hao-Chieh Chiu)*,Molecular epidemiology of bacteraemic vancomycin-resistant Enterococcus faecium isolates and in vitro activities of SC5005 and other comparators against these isolates collected from a medical centre in northern Taiwan, 2019-2020,JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY,2023 Feb,78(2):457-465,SCI
49 (Chih-Cheng Lai)、(Chi-Kuei Hsu)、(Shun-Chung Hsueh)、(Muh-Yong Yen)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*,Multisystem inflammatory syndrome in adults:Characteristics, treatment, and outcomes,JOURNAL OF MEDICAL VIROLOGY,2023 Feb,95(2):e28426,SCI
50 (Yu-Lin Lee)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*,Geographic patterns of Acinetobacter baumannii and carbapenem resistance in the Asia-Pacific Region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012-2019,INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES,2023 Feb,127(2023):48-55,SCI
51 (Seung Hyun Park)、(Sung Hwi Hong)、(Kwanghyun Kim)、(Seung Won Lee)、(Dong Keon Yon)、(Sun Jae Jung)*、(Ziad Abdeen)、(Ramy Abou Ghayda)、(Mohamed Lemine Cheikh Brahim Ahm)、(Abdulwahed Al Serouri)、薛博仁(Hsueh, Po-Ren),Non-Pharmaceutical Interventions Reduce the Incidence, and Mortality of COVID-19: A Study based on the Survey from the International COVID-19 Research Network (ICRN),JOURNAL OF MEDICAL VIROLOGY,2023 Feb,95(2):e28354,SCI
52 陳智皓(CHEN CHIH-HAO)、吳品瀚(WU PIN-HAN)、盧敏吉(Min-Chi Lu)、何茂旺(Mao-Wang Ho)、薛博仁(Hsueh, Po-Ren)*,National surveillance of antimicrobial susceptibilities to ceftaroline, dalbavancin, telavancin, tedizolid, eravacycline, omadacycline, and other comparator antibiotics, and genetic characteristics of bacteremic Staphylococcus aureus isolates in adults: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) program in 2020,International Journal of Antimicrobial Agents,2023 Feb,61(.):.-.,SCI
53 (Jia-Arng Lee)、(Shin-Hei Du)、(Tai-Fen Lee)、(Yu-Shan Huang)、(Chun-Hsing Liao)、(Yu-Tsung Huang)*、薛博仁(Hsueh, Po-Ren)*,Rapid emergence of ceftazidime-avibactam resistance among carbapenem-resistant Enterobacterales in a tertiary-care hospital in Taiwan,JOURNAL OF INFECTION,2023 Jan,86(1):66-117,SCI
54 (Yuag-Meng Liu)、(Wen-Chien Ko)、何茂旺(Mao-Wang Ho)、(Yu-Lin Lee)、薛博仁(Hsueh, Po-Ren)*,In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Pseudomonas aeruginosa in Taiwan: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) in 2020,JOURNAL OF INFECTION,2023 Jan,86(1):66-117,SCI
55 (Jia-Arng Lee)、(Tai-Fen Lee)、(Yu-Tsung Huang)、薛博仁(Hsueh, Po-Ren)*,Catheter-related bloodstream infection due to Bordetella trematum,JOURNAL OF INFECTION,2022 Dec,85(6):e175-e176,SCI
56 (Shio-Shin Jean)、(Hung-Jen Yang)、(Po-Chuen Hsieh)、(Yu-Tsung Huang)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*,In Vitro Susceptibilities of Worldwide Isolates of Intrapulmonary Aspergillus Species and Important Candida Species in Sterile Body Sites against Important Antifungals: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2017-2020,Microbiology Spectrum,2022 Dec,10(6):e0296522,SCI
57 (Xin-Fei Chen)、(Han Zhang)、(Xin-Miao Jia)、(Jin Cao)、(Li Li)、(Xin-Lan Hu)、(Ning Li)、(Yu-Ling Xiao)、(Fei Xia)、(Li-Yan Ye)、(Qing-Feng Hu)、(Xiao-Li Wu)、(Li-Ping Ning)、薛博仁(Hsueh, Po-Ren)、(Xin Fan)、(Shu-Ying Yu)、(Jing-Jing Huang)、(Xiu-Li Xie)、(Wen-Hang Yang)、(Ying-Xing Li)、(Ge Zhang)、(Jing-Jia Zhang)、(Si-Meng Duan)、(Wei Kang)、(Tong Wang)、(Jin Li)、(Meng Xiao)、(Xin Hou)、(Ying-Chun Xu)*,Antifungal susceptibility profiles and drug resistance mechanisms of clinical Candida duobushaemulonii isolates from China,Frontiers in Microbiology,2022 Dec,13():1001845,SCI
58 (Ting-KuangYeh)、(Hsueh-Ju Lin)、(Po-Yu Liu)、(Jui-Hsing Wang)*、薛博仁(Hsueh, Po-Ren)*,Antibiotic resistance in Enterobacter hormaechei,International Journal of Antimicrobial Agents,2022 Oct,60(4):106650,SCI
59 (Chih-Cheng Lai)、(Chi-Kuei Hsu)、(Muh-Yong Yen)、(Ping-Ing Lee)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*,Monkeypox: An emerging global threat during the COVID-19 pandemic,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2022 Oct,55(5):787-794,SCI
60 (Yuan-Pin Hung)、(Ching-Chi Lee)、(Jen-Chieh Lee)、(Chun-Wei Chiu)、薛博仁(Hsueh, Po-Ren)、(Wen-Chien Ko)*,A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2022 Oct,55(5):795-802,SCI
61 (Yu-Lin Lee)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*,Geographic patterns of global isolates of carbapenem-resistant Klebsiella pneumoniae and the activity of ceftazidime/avibactam, meropenem/vaborbactam, and comparators against these isolates: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020,International Journal of Antimicrobial Agents,2022 Oct,60():106679,SCI
62 游家鑫(Jiaxin Yu)、林秀姍(Hsiu-Hsien Lin)、曾坤浩(Kun-Hao Zeng)、田霓(Ni Tien)、薛博仁(Hsueh, Po-Ren)*、周德陽(Der-Yang Cho)*,Direct prediction of ceftazidime-resistant Stenotrophomonas maltophilia from routine MALDI-TOF mass spectra using machine learning,JOURNAL OF INFECTION,2022 Sep,():,SCI
63 張凱發(TEO KAI FA)、陳得源(Der-Yuan Chen)、徐婕婷(Jeh-Ting Hsu)、賴怡樺(LAI YI-HUA)、張敬昆、薛博仁(Hsueh, Po-Ren)、藍忠亮(Joung-Liang Lan)*、徐婕琳(Hsu, Jye-Lin)*,Screening and characterization of myositis-related autoantibodies in COVID-19 patients,CTS-Clinical and Translational Science,2022 Sep,00():1-11,SCI
64 (Muh-Yong Yen)*、(Jonathan Schwartz)、薛博仁(Hsueh, Po-Ren),The implications of the COVID-19 pandemic for long term care facilities,CURRENT OPINION IN INFECTIOUS DISEASES,2022 Aug,35(4):370-377,SCI
65 張煜昌(Yu-Chang Chang)、蕭瓊子(Chiung-Tzu Hsiao)、陳婉麗(Wan-Li Chen)、蘇揚迪(Yang-Di Su)、薛博仁(Hsueh, Po-Ren)*,BioFire FilmArray respiratory panel RP2.1 for SARS-CoV-2 detection: The pitfalls,JOURNAL OF INFECTION,2022 Aug,5(42):e1-e3,SCI
66 吳品瀚(WU PIN-HAN)、陳智皓(CHEN CHIH-HAO)、周家卉(Chia-Hui Chou)、何茂旺(Mao-Wang Ho)、劉于瑄(LIU YU-HSUAN)、林秀姍(Hsiu-Hsien Lin)、陳冠妃(Chen, Kuan-Fei)、薛博仁(Hsueh, Po-Ren)*,FilmArray Meningitis/Encephalitis (M/E) false-negative for cryptococcal meningitis,JOURNAL OF INFECTION,2022 Jul,85(1):90-122,SCI
67 林秀姍(Hsiu-Hsien Lin)、曾坤浩(Kun-Hao Zeng)、田霓(Ni Tien)、林瑜姿(Yu-Tzu Lin)、游家鑫(Jiaxin Yu)、薛博仁(Hsueh, Po-Ren)*、周德陽(Der-Yang Cho),Evaluation of the Rapid Sepsityper protocol and specific MBT-Sepsityper module for the identification of bacteremia and fungemia using Bruker Biotyper MALDI-TOF MS,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2022 Jul,():,SCI
68 陳筱凡(Chen Hsiao-Fan)、薛博仁(Hsueh, Po-Ren)、劉儼毅(Yen-Yi Liu)、陳曄(Chen,Yeh)、(Sui-Yuan Chang)、王韋然(Wang, Wei-Jan)、吳承修(Wu, Chen-Shiou)、(Ya-Min Tsai)、(Yu-Shu Liu)、蘇文琪(Wen-Chi Su)、(Yu-Chi Chou)、洪明奇(Mien-Chie Hung)*,Disulfiram blocked cell entry of SARS-CoV-2 via inhibiting the interaction of spike protein and ACE2,American Journal of Cancer Research,2022 Jul,12(7):3333-3346,SCI
69 (JUNG-YIEN CHIEN)、(Chong-Jen Yu)、薛博仁(Hsueh, Po-Ren)*,Utility of Metagenomic Next-Generation Sequencing for Etiological Diagnosis of Patients with Sepsis in Intensive Care Units,Microbiology Spectrum,2022 Jul,10(4):e0074622,SCI
70 (Yi-Min Huang)、(Cheng-Hsun Lu)、(Chiao-Feng Cheng)、(Chieh-Yu Shen)、(Song-Chou Hsieh)、(Ko-Jen Li)*、(Jung-Yien Chien)、薛博仁(Hsueh, Po-Ren)、(TACTICS Study Group),Clinical features and prognostic predictors in patients with rheumatic diseases complicated by Pneumocystis pneumonia,INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES,2022 Jul,122():1018-1025,SCI
71 曾宇銓(Yu-chuan Tseng)、林柏謙(Peter Bor-Chian Lin)、蕭瓊子(Chiung-Tzu Hsiao)、薛博仁(Hsueh, Po-Ren)*,Multiplex PCR rapid testing for meningitis/encephalitis,JOURNAL OF INFECTION,2022 Jun,84(6):834-872,SCI
72 (Shio-Shin Jean)、(Wen-Chien Ko)、(Min-Chi Lu)、(Wen-Sen Lee)、薛博仁(Hsueh, Po-Ren)*、(SMART Program),Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii complex causing bloodstream infection in Taiwan, 2020,Expert Review of Anti-Infective Therapy,2022 Jun,20(6):941-953,SCI
73 (Mitsunori Yoshida)、(Jung-Yien Chien)、(Kozo Morimoto)、(Takeshi Kinjo)、(Akio Aono)、(Yoshiro Murase)、(Keiji Fujiwara)、(Yuta Morishige)、(Hiroaki Nagano)、(Ruwen Jou)、(Naoki Hasegawa)、(Manabu Ato)、(Yoshihiko Hoshino)、薛博仁(Hsueh, Po-Ren)*、(Satoshi Mitarai),Molecular Epidemiological Characteristics of Mycobacterium abscessus Complex Derived from Non-Cystic Fibrosis Patients in Japan and Taiwan,Microbiology Spectrum,2022 Jun,10(3):e0057122,SCI
74 (Chun-Min Kang)、(Nan-Yao Lee)、(Chih-Hsueh Lin)、(Yuan-Shan Hsu)、(Yu-Chang Chang)、(Ming-Yi Chung)、(Ya-Fan Lee)、(Wen-Pin Tseng)、(Jhong-Lin Wu)、(Shey-Ying Chen)、盧敏吉(Min-Chi Lu)*、(Wen-Chien Ko)*、(Ping-Ing Lee)*、薛博仁(Hsueh, Po-Ren)*,Immunogenicity and safety of homologous and heterologous ChAdOx1-S and mRNA-1273 vaccinations in healthy adults in Taiwan,JOURNAL OF CLINICAL VIROLOGY,2022 Jun,150(Jun):150-151,SCI
75 (Tsai-Wen Wan)、(Yu-Jung Liu)、(Yu-Ting Wang)、林瑜姿(Yu-Tzu Lin)、(Jia-Chuan Hsu)、(Jui-Chang Tsai)、(Hao-Chieh Chiu)、薛博仁(Hsueh, Po-Ren)、(Wei-Chun Hung)*、(Lee-Jene Teng)*,Potentially conjugative plasmids harboring Tn6636 , a multidrug-resistant and composite mobile element, in Staphylococcus aureus,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2022 Apr,55(2):225-233,SCI
76 田霓(Ni Tien)、張煜昌(Yu-Chang Chang)、陳柏谷(PoKu Chen)、林惠茹(Hui-Ju Lin)、張詩欣(Shih-Hsin Chang)、藍忠亮(Joung-Liang Lan)、薛博仁(Hsueh, Po-Ren)、張敬昆、陳得源(Der-Yuan Chen)*,The Immunogenicity and Safety of Three Types of SARS-CoV-2 Vaccines in Adult Patients with Immune-Mediated Inflammatory Diseases: A Longitudinal Cohort Study,Biomedicines,2022 Apr,10(4):911,SCI
77 (Shio-Shin Jean)、盧敏吉(Min-Chi Lu)、何茂旺(Mao-Wang Ho)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*,Non-susceptibilities to antibiotics against important Gram-negative bacteria, and imipenem-relebactam, meropenem-vaborbactam against carbapenem non-susceptible Enterobacterales and Pseudomonas aeruginosa isolates implicated in complicated intra-abdominal and urinary tract infections in Taiwan, 2019,International Journal of Antimicrobial Agents,2022 Mar,59(3):106521,SCI
78 (Yoshinori Yamano)*、(NaokiI shibashi)、(Miho Kuroiwa)、(Miki Takemura)、(Wang-Huei Sheng)、薛博仁(Hsueh, Po-Ren)*,Characterisation of cefiderocol-non-susceptible Acinetobacter baumannii isolates from Taiwan,Journal of Global Antimicrobial Resistance,2022 Mar,28():120-124,SCI
79 (Wei-Yao Wang)、薛博仁(Hsueh, Po-Ren)、(Shih-Ming Tsao)*,Genotyping of methicillin-resistant Staphylococcus aureus isolates causing invasive infections using spa typing and their correlation with antimicrobial susceptibility,International Journal of Antimicrobial Agents,2022 Mar,59(3):106525,SCI
80 (Chun-Hsing Liao)、(Yu-Tsung Huang)、薛博仁(Hsueh, Po-Ren)*,Multicenter surveillance of capsular serotypes, virulence genes, and antimicrobial susceptibilities of Klebsiella pneumoniae causing bacteremia in Taiwan, 2017-2019,Frontiers in Microbiology,2022 Mar,13():783523,SCI
81 (Shio-Shin Jean)、(Dorji Harnod)、薛博仁(Hsueh, Po-Ren)*,Global Threat of Carbapenem-Resistant Gram-Negative Bacteria,Frontiers in Cellular and Infection Microbiology,2022 Mar,12():823684,SCI
82 (Yu-Lin Lee)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*,Geographic Patterns of Carbapenem-Resistant Pseudomonas aeruginosa in the Asia-Pacific Region: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) Program, 2015–2019,ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,2022 Feb,66(2):,SCI
83 (Yu-Lin Lee)、(Hsien-Meng Chen)、(Ing-Moi Hii)、薛博仁(Hsueh, Po-Ren)*,Carbapenemase-producing Enterobacterales infections: recent advances in diagnosis and treatment,International Journal of Antimicrobial Agents,2022 Feb,59(2):106528,SCI
84 林瑜姿(Yu-Tzu Lin)*、(Wei-Chun Hung)、(Tsai-Wen Wan)、(Hsin Li)、(Tai-Fen Lee)、薛博仁(Hsueh, Po-Ren)、(Lee-Jene Teng)*,Staphylococcus taiwanensis sp. nov., isolated from human blood,INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY,2022 Feb,72(2):005262,SCI
85 (Ting-Kuang Yeh)、(Shio-Shin Jean)、(Yu-Lin Lee)、盧敏吉(Min-Chi Lu)、(Wen-Chien Ko)、(Hsueh-Ju Lin)、(Po-Yu Liu)*、薛博仁(Hsueh, Po-Ren)*,Bacteriophages and phage-delivered CRISPR-Cas system as antibacterial therapy,International Journal of Antimicrobial Agents,2022 Jan,59(1):,SCI
86 (Yu-Tsung Huang)、(Yao-Wen Kuo)、(Nan-Yao Lee)、田霓(Ni Tien)、(Chun-Hsing Liao)、(h Lee-Jene Teng)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*,Evaluating NG-Test CARBA 5 Multiplex immunochromatographic and Cepheid Xpert CARBA-R assays among carbapenem-Resistant Enterobacterales isolates associated with bloodstream infection,Microbiology Spectrum,2022 Jan,10(1):e01728-21,SCI
87 薛博仁(Hsueh, Po-Ren),Clostridioides difficile infection: an emerging zoonosis?,Expert Review of Anti-Infective Therapy,2021 Dec,19(12):1543-1552,SCI
88 (Chen, Sharon C-A)*、(Perfect, John)、(Colombo, Arnaldo L.)、(Cornely, Oliver A.)、(Groll, Andreas H.)、(Seidel, Danila)、薛博仁(Hsueh, Po-Ren)、(Ip, Margaret)、(Munoz, Patricia),Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM,LANCET INFECTIOUS DISEASES,2021 Dec,21(12):375-386,SCI
89 (Meng-Lan Zhou)、(Zi-Ran Wang)、(Yan-Bing Li)、(Timothy Kudinha)、(Jian Wang)、(Yao Wang)、(Meng Xiao)、(Ying-Chun Xu)*、(Zheng-Yin Liu)*、薛博仁(Hsueh, Po-Ren)*,Rapid identification of Streptococcus pneumoniae serotypes by cpsB gene-based sequetyping combined with multiplex PCR,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2021 Nov,S1684-1182():,SCI
90 (Chih-Cheng Lai)、(Chien-Ming Chao)、薛博仁(Hsueh, Po-Ren)*,Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2021 Oct,54(5):767-775,SCI
91 (Chun-Hsing Liaoe)*、薛博仁(HSUEH PO-REN)*,Comparison of Etest and broth microdilution for evaluating the susceptibility of Staphylococcus aureus and Streptococcus pneumoniae to ceftaroline and of carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa to ceftazidime/avibactam,Journal of Global Antimicrobial Resistance,2021 Sep,26():301-307,SCI
92 薛博仁(Hsueh, Po-Ren)*、(Wen-Chien Ko)*,The Potential of Probiotics to Eradicate Gut Carriage of Pathogenic or Antimicrobial-Resistant Enterobacterales,Antibiotics-Basel,2021 Sep,10(9):1086,SCI
93 (Shio-Shin Jean)、(Yu-Lin Lee)、(Po-Yu Liu)、盧敏吉(Min-Chi Lu)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*,Multicenter surveillance of antimicrobial susceptibilities and resistance mechanisms among Enterobacterales species and non-fermenting Gram-negative bacteria from different infection sources in Taiwan from 2016 to 2018,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2021 Sep,3(21):00182-1-00182-1,SCI
94 盧敏吉(Min-Chi Lu)、薛博仁(Hsueh, Po-Ren)*,National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017–2020,Journal of Global Antimicrobial Resistance,2021 Aug,26():308-316,SCI
95 薛博仁(Hsueh, Po-Ren)*、(d Peck Toung Ooi)*,Animal Coronavirus Diseases: Parallels with COVID-19 in Humans,Viruses-Basel,2021 Aug,13(8):1507,SCI
96 (Po-Yu Liu)、(Wen-Chien Ko)、(Wen-Sen Lee)、(Po-Liang Lu)、(Yen-Hsu Chen)、(Shu-Hsing Cheng)、盧敏吉(Min-Chi Lu)、(Chi-Ying Lin)、(Ting-Shu Wu)、(Muh-Yong Yen)、(Lih-Shinn Wang)、(Chang-Pan Liu)、(Pei-Lan Shao)、(Yu-Lin Lee)、(Zhi-Yuan Shi)、(Yao-Shen Chen)、(Fu-Der Wang)、(Shu-Hui Tseng)、(Chao-Nan Lin)、(Yu-Hui Chen)、(Wang-Huei Sheng)、(Chun-Ming Lee)、(Hung-Jen Tang)、薛博仁(Hsueh, Po-Ren)*,In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018-2020,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2021 Aug,4(21):00186-00189,SCI
97 (Chih-Cheng Lai)、(Wen-Chien Ko)、(Chih-Jung Chen)、(Po-Yen Chen)、(Yhu-Chering Huang)、(Ping-Ing Lee)*、薛博仁(Hsueh, Po-Ren)*,COVID-19 vaccines and thrombosis with thrombocytopenia syndrome,Expert Review of Vaccines,2021 Aug,20(8):1027-1035,SCI
98 (Chih-Cheng Lai)、(I-Tzu Chen)、(Chien-Ming Chao)、(Ping-Ing Lee)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*,COVID-19 vaccines: concerns beyond protective efficacy and safety,Expert Review of Vaccines,2021 Aug,20(8):1013-1025,SCI
99 (Ying-Chun Xu)*、薛博仁(Hsueh, Po-Ren)*,Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) Analysis for the Identification of Pathogenic Microorganisms: A Review,Microorganisms,2021 Jul,9(7):1536,SCI
100 (Hsih-Yeh Tsai)、(Yu-Lin Lee)、(Po-Yu Liu)、盧敏吉(Min-Chi Lu)、(Pei-Lan Shao)、(Po-Liang Lu)、(Shu-Hsing Cheng)、(Wen-Chien Ko)、(Chi-Ying Lin)、(Ting-Shu Wu)、(Muh-Yong Yen)、(Lih-Shinn Wang)、(Chang-Pan Liu)、(Wen-Sen Lee)、(Zhi-Yuan Shi)、(Yao-Shen Chen)、(Fu-Der Wang)、(Shu-Hui Tseng)、(Yu-Hui Chen)、(Wang-Huei Sheng)、(Chun-Ming Lee)、(Yen-Hsu Chen)、(Chun-Hsing Liao)、薛博仁(Hsueh, Po-Ren)*,Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019-2020 Nationwide Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART),International Journal of Antimicrobial Agents,2021 Jul,58(1):106353-106353,SCI
101 (Yu-Te Tsai)、(Yu-Lin Lee)、盧敏吉(Min-Chi Lu)、(Pei-Lan Shao)、(Po-Liang Lu)、(Shu-Hsing Cheng)、(Wen-Chien Ko)、(Chi-Ying Lin)、(Ting-Shu Wu)、(Muh-Yong Yen)、(Lih-Shinn Wang)、(Chang-Pan Liu)、(Wen-Sen Lee)、(Zhi-Yuan Shi)、(Yao-Shen Chen)、(Fu-Der Wang)、(Shu-Hui Tseng)、(Chao-Nan Lin)、(Yu-Hui Chen)、(Wang-Huei Sheng)、(Chun-Ming Lee)、(Hung-Jen Tang)、(Chun-Yu Lin)、(Yen-Hsu Chen)*、薛博仁(Hsueh, Po-Ren)*,Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2021 Jun,2021(21):00105-00105,SCI
102 (Yu-Lin Lee)、(Wen-Chien Ko)、(Wen-Sen Lee)、(Po-Liang Lu)、(Yen-Hsu Chen)、(Shu-Hsing Cheng)、盧敏吉(Min-Chi Lu)、(Chi-Ying Lin)、(Ting-Shu Wu)、(Muh-Yong Yen)、(Lih-Shinn Wang)、(Chang-Pan Liu)、(Pei-Lan Shao)、(Zhi-Yuan Shi)、(Yao-Shen Chen)、(Fu-Der Wang)、(Shu-Hui Tseng)、(Chao-Nan Lin)、(Yu-Hui Chen)、(Wang-Huei Sheng)、(Chun-Ming Lee)、(Hung-Jen Tang)、薛博仁(Hsueh, Po-Ren)*,In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017–2020,International Journal of Antimicrobial Agents,2021 Jun,2021(58):106377-106377,SCI
103 (Chih-Cheng Lai)、(Chin-Te Lu)、(Kuo-Chin Kao)、盧敏吉(Min-Chi Lu)、(Wen-Chien Ko)、薛博仁(Hsueh, Po-Ren)*,Association of fluoroquinolones use with the risk of aortic aneurysm or aortic dissection: Facts and myths,JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2021 Apr,54(2):182-184,SCI
104 鄭心瑜(Hsin-Yu Cheng)、(Shio-Shin Jean)、(Yu-Lin Lee)、盧敏吉(Min-Chi Lu)、(Wen-Chien Ko)、(Po-Yu Liu)、薛博仁(Hsueh, Po-Ren)*,Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review,Frontiers in Cellular and Infection Microbiology,2021 Apr,23(11):601968-601968,SCI